NCT05083286View on ClinicalTrials.gov

Duration of Botox Using OLD Versus COLD for Treatment of Glabellar Lines

EARLY_PHASE1UnknownINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

October 20, 2021

Primary Completion Date

August 1, 2022

Study Completion Date

August 1, 2022

Conditions
Glabellar Frown Lines
Interventions
DRUG

OnabotulinumtoxinA

Injection of glabellar rhytids

Trial Locations (2)

91436

RECRUITING

Clinical Testing of Beverly Hills, Encino

92663

RECRUITING

Steve Yoelin MD, Newport Beach

Sponsors

Collaborators (1)

Allergan
All Listed Sponsors
collaborator

Allergan

INDUSTRY

lead

Clinical Testing of Beverly Hills

OTHER

NCT05083286 - Duration of Botox Using OLD Versus COLD for Treatment of Glabellar Lines | Biotech Hunter | Biotech Hunter